nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP2C19—Rosuvastatin—atherosclerosis	0.0802	0.121	CbGbCtD
Guanfacine—CYP2C19—Simvastatin—atherosclerosis	0.0746	0.113	CbGbCtD
Guanfacine—CYP2C19—Lovastatin—atherosclerosis	0.073	0.11	CbGbCtD
Guanfacine—CYP2C9—Rosuvastatin—atherosclerosis	0.0667	0.101	CbGbCtD
Guanfacine—CYP2C9—Simvastatin—atherosclerosis	0.062	0.0937	CbGbCtD
Guanfacine—CYP2C9—Pravastatin—atherosclerosis	0.0607	0.0917	CbGbCtD
Guanfacine—CYP2C9—Lovastatin—atherosclerosis	0.0607	0.0917	CbGbCtD
Guanfacine—CYP3A4—Rosuvastatin—atherosclerosis	0.0388	0.0586	CbGbCtD
Guanfacine—CYP3A4—Ezetimibe—atherosclerosis	0.0388	0.0586	CbGbCtD
Guanfacine—CYP3A4—Simvastatin—atherosclerosis	0.0361	0.0545	CbGbCtD
Guanfacine—CYP3A4—Pravastatin—atherosclerosis	0.0353	0.0533	CbGbCtD
Guanfacine—CYP3A4—Lovastatin—atherosclerosis	0.0353	0.0533	CbGbCtD
Guanfacine—Diclofenac—PLA2G2A—atherosclerosis	0.0046	0.55	CrCbGaD
Guanfacine—Nightmare—Rosuvastatin—atherosclerosis	0.0025	0.011	CcSEcCtD
Guanfacine—Renal failure acute—Rosuvastatin—atherosclerosis	0.00203	0.00893	CcSEcCtD
Guanfacine—Amnesia—Rosuvastatin—atherosclerosis	0.002	0.00877	CcSEcCtD
Guanfacine—Nocturia—Pravastatin—atherosclerosis	0.002	0.00877	CcSEcCtD
Guanfacine—Nightmare—Simvastatin—atherosclerosis	0.00198	0.00869	CcSEcCtD
Guanfacine—Skin exfoliation—Niacin—atherosclerosis	0.0018	0.00789	CcSEcCtD
Guanfacine—Nightmare—Pravastatin—atherosclerosis	0.00179	0.00786	CcSEcCtD
Guanfacine—Vascular purpura—Lovastatin—atherosclerosis	0.00178	0.00781	CcSEcCtD
Guanfacine—Cramps of lower extremities—Niacin—atherosclerosis	0.00173	0.00759	CcSEcCtD
Guanfacine—Amnesia—Lovastatin—atherosclerosis	0.00169	0.00743	CcSEcCtD
Guanfacine—Vascular purpura—Simvastatin—atherosclerosis	0.00166	0.0073	CcSEcCtD
Guanfacine—Amnesia—Ezetimibe—atherosclerosis	0.00166	0.00729	CcSEcCtD
Guanfacine—Purpura—Lovastatin—atherosclerosis	0.00165	0.00725	CcSEcCtD
Guanfacine—Diclofenac—ALOX5—atherosclerosis	0.00165	0.197	CrCbGaD
Guanfacine—Pain in extremity—Lovastatin—atherosclerosis	0.00159	0.00698	CcSEcCtD
Guanfacine—Amnesia—Simvastatin—atherosclerosis	0.00158	0.00695	CcSEcCtD
Guanfacine—Pain in extremity—Ezetimibe—atherosclerosis	0.00156	0.00685	CcSEcCtD
Guanfacine—Purpura—Simvastatin—atherosclerosis	0.00154	0.00678	CcSEcCtD
Guanfacine—Vascular purpura—Pravastatin—atherosclerosis	0.0015	0.0066	CcSEcCtD
Guanfacine—Renal failure acute—Pravastatin—atherosclerosis	0.00146	0.0064	CcSEcCtD
Guanfacine—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00144	0.00632	CcSEcCtD
Guanfacine—Amnesia—Pravastatin—atherosclerosis	0.00143	0.00629	CcSEcCtD
Guanfacine—Purpura—Pravastatin—atherosclerosis	0.0014	0.00613	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00138	0.00604	CcSEcCtD
Guanfacine—Diclofenac—CXCL8—atherosclerosis	0.00137	0.163	CrCbGaD
Guanfacine—Affect lability—Pravastatin—atherosclerosis	0.00132	0.00581	CcSEcCtD
Guanfacine—Abdominal discomfort—Lovastatin—atherosclerosis	0.00132	0.00579	CcSEcCtD
Guanfacine—Rhinitis—Rosuvastatin—atherosclerosis	0.0013	0.00572	CcSEcCtD
Guanfacine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00127	0.00556	CcSEcCtD
Guanfacine—Liver function test abnormal—Niacin—atherosclerosis	0.00126	0.00554	CcSEcCtD
Guanfacine—Orthostatic hypotension—Niacin—atherosclerosis	0.00125	0.00548	CcSEcCtD
Guanfacine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00124	0.00545	CcSEcCtD
Guanfacine—Liver function test abnormal—Pravastatin—atherosclerosis	0.00124	0.00545	CcSEcCtD
Guanfacine—Abdominal discomfort—Simvastatin—atherosclerosis	0.00123	0.00541	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00119	0.00521	CcSEcCtD
Guanfacine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00118	0.0052	CcSEcCtD
Guanfacine—Dysphagia—Niacin—atherosclerosis	0.00118	0.00518	CcSEcCtD
Guanfacine—Erectile dysfunction—Niacin—atherosclerosis	0.00109	0.00477	CcSEcCtD
Guanfacine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00107	0.0047	CcSEcCtD
Guanfacine—Weight increased—Pravastatin—atherosclerosis	0.00106	0.00465	CcSEcCtD
Guanfacine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00102	0.00449	CcSEcCtD
Guanfacine—Myocardial infarction—Pravastatin—atherosclerosis	0.00102	0.00446	CcSEcCtD
Guanfacine—Sweating—Niacin—atherosclerosis	0.00101	0.00443	CcSEcCtD
Guanfacine—Immune system disorder—Ezetimibe—atherosclerosis	0.000975	0.00428	CcSEcCtD
Guanfacine—Alopecia—Lovastatin—atherosclerosis	0.000972	0.00427	CcSEcCtD
Guanfacine—Arthralgia—Rosuvastatin—atherosclerosis	0.000962	0.00423	CcSEcCtD
Guanfacine—Myalgia—Rosuvastatin—atherosclerosis	0.000962	0.00423	CcSEcCtD
Guanfacine—Alopecia—Ezetimibe—atherosclerosis	0.000954	0.00419	CcSEcCtD
Guanfacine—Rhinitis—Niacin—atherosclerosis	0.000948	0.00416	CcSEcCtD
Guanfacine—Dysgeusia—Lovastatin—atherosclerosis	0.000938	0.00412	CcSEcCtD
Guanfacine—Rhinitis—Pravastatin—atherosclerosis	0.000933	0.0041	CcSEcCtD
Guanfacine—Confusional state—Rosuvastatin—atherosclerosis	0.00093	0.00408	CcSEcCtD
Guanfacine—Muscle spasms—Lovastatin—atherosclerosis	0.000921	0.00404	CcSEcCtD
Guanfacine—Visual impairment—Niacin—atherosclerosis	0.000911	0.004	CcSEcCtD
Guanfacine—Alopecia—Simvastatin—atherosclerosis	0.00091	0.00399	CcSEcCtD
Guanfacine—Muscle spasms—Ezetimibe—atherosclerosis	0.000903	0.00397	CcSEcCtD
Guanfacine—Vision blurred—Lovastatin—atherosclerosis	0.000903	0.00396	CcSEcCtD
Guanfacine—Tremor—Lovastatin—atherosclerosis	0.000898	0.00394	CcSEcCtD
Guanfacine—Visual impairment—Pravastatin—atherosclerosis	0.000897	0.00394	CcSEcCtD
Guanfacine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000889	0.0039	CcSEcCtD
Guanfacine—Eye disorder—Niacin—atherosclerosis	0.000883	0.00388	CcSEcCtD
Guanfacine—Tinnitus—Niacin—atherosclerosis	0.000881	0.00387	CcSEcCtD
Guanfacine—Dysgeusia—Simvastatin—atherosclerosis	0.000878	0.00385	CcSEcCtD
Guanfacine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000872	0.00383	CcSEcCtD
Guanfacine—Tinnitus—Pravastatin—atherosclerosis	0.000868	0.00381	CcSEcCtD
Guanfacine—Malaise—Lovastatin—atherosclerosis	0.000864	0.00379	CcSEcCtD
Guanfacine—Muscle spasms—Simvastatin—atherosclerosis	0.000862	0.00378	CcSEcCtD
Guanfacine—Vertigo—Lovastatin—atherosclerosis	0.000861	0.00378	CcSEcCtD
Guanfacine—Malaise—Ezetimibe—atherosclerosis	0.000847	0.00372	CcSEcCtD
Guanfacine—Vision blurred—Simvastatin—atherosclerosis	0.000845	0.00371	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000841	0.00369	CcSEcCtD
Guanfacine—Tremor—Simvastatin—atherosclerosis	0.00084	0.00369	CcSEcCtD
Guanfacine—Alopecia—Niacin—atherosclerosis	0.000835	0.00367	CcSEcCtD
Guanfacine—Insomnia—Rosuvastatin—atherosclerosis	0.000834	0.00366	CcSEcCtD
Guanfacine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000831	0.00365	CcSEcCtD
Guanfacine—Palpitations—Ezetimibe—atherosclerosis	0.00083	0.00365	CcSEcCtD
Guanfacine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000828	0.00364	CcSEcCtD
Guanfacine—Alopecia—Pravastatin—atherosclerosis	0.000822	0.00361	CcSEcCtD
Guanfacine—Chest pain—Lovastatin—atherosclerosis	0.000816	0.00358	CcSEcCtD
Guanfacine—Myalgia—Lovastatin—atherosclerosis	0.000816	0.00358	CcSEcCtD
Guanfacine—Arthralgia—Lovastatin—atherosclerosis	0.000816	0.00358	CcSEcCtD
Guanfacine—Anxiety—Lovastatin—atherosclerosis	0.000813	0.00357	CcSEcCtD
Guanfacine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000812	0.00357	CcSEcCtD
Guanfacine—Hypertension—Ezetimibe—atherosclerosis	0.000811	0.00356	CcSEcCtD
Guanfacine—Malaise—Simvastatin—atherosclerosis	0.000808	0.00355	CcSEcCtD
Guanfacine—Tension—Niacin—atherosclerosis	0.000807	0.00354	CcSEcCtD
Guanfacine—Discomfort—Lovastatin—atherosclerosis	0.000806	0.00354	CcSEcCtD
Guanfacine—Vertigo—Simvastatin—atherosclerosis	0.000805	0.00353	CcSEcCtD
Guanfacine—Chest pain—Ezetimibe—atherosclerosis	0.0008	0.00351	CcSEcCtD
Guanfacine—Myalgia—Ezetimibe—atherosclerosis	0.0008	0.00351	CcSEcCtD
Guanfacine—Arthralgia—Ezetimibe—atherosclerosis	0.0008	0.00351	CcSEcCtD
Guanfacine—Nervousness—Niacin—atherosclerosis	0.000799	0.00351	CcSEcCtD
Guanfacine—Dry mouth—Lovastatin—atherosclerosis	0.000798	0.0035	CcSEcCtD
Guanfacine—Tension—Pravastatin—atherosclerosis	0.000795	0.00349	CcSEcCtD
Guanfacine—Dysgeusia—Pravastatin—atherosclerosis	0.000793	0.00348	CcSEcCtD
Guanfacine—Muscle spasms—Niacin—atherosclerosis	0.000791	0.00347	CcSEcCtD
Guanfacine—Discomfort—Ezetimibe—atherosclerosis	0.00079	0.00347	CcSEcCtD
Guanfacine—Constipation—Rosuvastatin—atherosclerosis	0.000789	0.00346	CcSEcCtD
Guanfacine—Confusional state—Lovastatin—atherosclerosis	0.000788	0.00346	CcSEcCtD
Guanfacine—Nervousness—Pravastatin—atherosclerosis	0.000787	0.00345	CcSEcCtD
Guanfacine—Dry mouth—Ezetimibe—atherosclerosis	0.000782	0.00343	CcSEcCtD
Guanfacine—Muscle spasms—Pravastatin—atherosclerosis	0.000779	0.00342	CcSEcCtD
Guanfacine—Vision blurred—Niacin—atherosclerosis	0.000775	0.0034	CcSEcCtD
Guanfacine—Confusional state—Ezetimibe—atherosclerosis	0.000773	0.00339	CcSEcCtD
Guanfacine—Vision blurred—Pravastatin—atherosclerosis	0.000763	0.00335	CcSEcCtD
Guanfacine—Arthralgia—Simvastatin—atherosclerosis	0.000763	0.00335	CcSEcCtD
Guanfacine—Chest pain—Simvastatin—atherosclerosis	0.000763	0.00335	CcSEcCtD
Guanfacine—Myalgia—Simvastatin—atherosclerosis	0.000763	0.00335	CcSEcCtD
Guanfacine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00076	0.00334	CcSEcCtD
Guanfacine—Anxiety—Simvastatin—atherosclerosis	0.00076	0.00334	CcSEcCtD
Guanfacine—Tremor—Pravastatin—atherosclerosis	0.000759	0.00333	CcSEcCtD
Guanfacine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000754	0.00331	CcSEcCtD
Guanfacine—Discomfort—Simvastatin—atherosclerosis	0.000754	0.00331	CcSEcCtD
Guanfacine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000752	0.0033	CcSEcCtD
Guanfacine—Vertigo—Niacin—atherosclerosis	0.000739	0.00325	CcSEcCtD
Guanfacine—Syncope—Niacin—atherosclerosis	0.000738	0.00324	CcSEcCtD
Guanfacine—Confusional state—Simvastatin—atherosclerosis	0.000737	0.00324	CcSEcCtD
Guanfacine—Oedema—Simvastatin—atherosclerosis	0.000731	0.00321	CcSEcCtD
Guanfacine—Malaise—Pravastatin—atherosclerosis	0.000731	0.00321	CcSEcCtD
Guanfacine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000729	0.0032	CcSEcCtD
Guanfacine—Vertigo—Pravastatin—atherosclerosis	0.000728	0.0032	CcSEcCtD
Guanfacine—Palpitations—Niacin—atherosclerosis	0.000727	0.00319	CcSEcCtD
Guanfacine—Loss of consciousness—Niacin—atherosclerosis	0.000723	0.00317	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000712	0.00313	CcSEcCtD
Guanfacine—Insomnia—Lovastatin—atherosclerosis	0.000707	0.0031	CcSEcCtD
Guanfacine—Paraesthesia—Lovastatin—atherosclerosis	0.000702	0.00308	CcSEcCtD
Guanfacine—Myalgia—Niacin—atherosclerosis	0.0007	0.00308	CcSEcCtD
Guanfacine—Arthralgia—Niacin—atherosclerosis	0.0007	0.00308	CcSEcCtD
Guanfacine—Hypertension—Pravastatin—atherosclerosis	0.000699	0.00307	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000699	0.00307	CcSEcCtD
Guanfacine—Dyspnoea—Lovastatin—atherosclerosis	0.000697	0.00306	CcSEcCtD
Guanfacine—Insomnia—Ezetimibe—atherosclerosis	0.000694	0.00304	CcSEcCtD
Guanfacine—Myalgia—Pravastatin—atherosclerosis	0.00069	0.00303	CcSEcCtD
Guanfacine—Chest pain—Pravastatin—atherosclerosis	0.00069	0.00303	CcSEcCtD
Guanfacine—Arthralgia—Pravastatin—atherosclerosis	0.00069	0.00303	CcSEcCtD
Guanfacine—Paraesthesia—Ezetimibe—atherosclerosis	0.000689	0.00302	CcSEcCtD
Guanfacine—Dyspepsia—Lovastatin—atherosclerosis	0.000688	0.00302	CcSEcCtD
Guanfacine—Anxiety—Pravastatin—atherosclerosis	0.000687	0.00302	CcSEcCtD
Guanfacine—Dry mouth—Niacin—atherosclerosis	0.000685	0.00301	CcSEcCtD
Guanfacine—Dyspnoea—Ezetimibe—atherosclerosis	0.000684	0.003	CcSEcCtD
Guanfacine—Discomfort—Pravastatin—atherosclerosis	0.000681	0.00299	CcSEcCtD
Guanfacine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00068	0.00298	CcSEcCtD
Guanfacine—Decreased appetite—Lovastatin—atherosclerosis	0.00068	0.00298	CcSEcCtD
Guanfacine—Dyspepsia—Ezetimibe—atherosclerosis	0.000675	0.00296	CcSEcCtD
Guanfacine—Fatigue—Lovastatin—atherosclerosis	0.000674	0.00296	CcSEcCtD
Guanfacine—Oedema—Niacin—atherosclerosis	0.000672	0.00295	CcSEcCtD
Guanfacine—Constipation—Lovastatin—atherosclerosis	0.000669	0.00294	CcSEcCtD
Guanfacine—Confusional state—Pravastatin—atherosclerosis	0.000667	0.00293	CcSEcCtD
Guanfacine—Decreased appetite—Ezetimibe—atherosclerosis	0.000667	0.00293	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000666	0.00293	CcSEcCtD
Guanfacine—Asthenia—Rosuvastatin—atherosclerosis	0.000662	0.00291	CcSEcCtD
Guanfacine—Insomnia—Simvastatin—atherosclerosis	0.000661	0.0029	CcSEcCtD
Guanfacine—Oedema—Pravastatin—atherosclerosis	0.000661	0.0029	CcSEcCtD
Guanfacine—Fatigue—Ezetimibe—atherosclerosis	0.000661	0.0029	CcSEcCtD
Guanfacine—Shock—Niacin—atherosclerosis	0.000661	0.0029	CcSEcCtD
Guanfacine—Paraesthesia—Simvastatin—atherosclerosis	0.000657	0.00288	CcSEcCtD
Guanfacine—Constipation—Ezetimibe—atherosclerosis	0.000656	0.00288	CcSEcCtD
Guanfacine—Tachycardia—Niacin—atherosclerosis	0.000655	0.00288	CcSEcCtD
Guanfacine—Pruritus—Rosuvastatin—atherosclerosis	0.000653	0.00287	CcSEcCtD
Guanfacine—Dyspnoea—Simvastatin—atherosclerosis	0.000652	0.00286	CcSEcCtD
Guanfacine—Hyperhidrosis—Niacin—atherosclerosis	0.000649	0.00285	CcSEcCtD
Guanfacine—Feeling abnormal—Lovastatin—atherosclerosis	0.000644	0.00283	CcSEcCtD
Guanfacine—Dyspepsia—Simvastatin—atherosclerosis	0.000644	0.00283	CcSEcCtD
Guanfacine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000639	0.00281	CcSEcCtD
Guanfacine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000639	0.00281	CcSEcCtD
Guanfacine—Decreased appetite—Simvastatin—atherosclerosis	0.000636	0.00279	CcSEcCtD
Guanfacine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000632	0.00277	CcSEcCtD
Guanfacine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000631	0.00277	CcSEcCtD
Guanfacine—Fatigue—Simvastatin—atherosclerosis	0.000631	0.00277	CcSEcCtD
Guanfacine—Hypotension—Niacin—atherosclerosis	0.000627	0.00275	CcSEcCtD
Guanfacine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000627	0.00275	CcSEcCtD
Guanfacine—Constipation—Simvastatin—atherosclerosis	0.000625	0.00275	CcSEcCtD
Guanfacine—Abdominal pain—Lovastatin—atherosclerosis	0.000618	0.00271	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000612	0.00269	CcSEcCtD
Guanfacine—Dizziness—Rosuvastatin—atherosclerosis	0.00061	0.00268	CcSEcCtD
Guanfacine—Insomnia—Niacin—atherosclerosis	0.000607	0.00267	CcSEcCtD
Guanfacine—Abdominal pain—Ezetimibe—atherosclerosis	0.000606	0.00266	CcSEcCtD
Guanfacine—Paraesthesia—Niacin—atherosclerosis	0.000603	0.00265	CcSEcCtD
Guanfacine—Feeling abnormal—Simvastatin—atherosclerosis	0.000603	0.00265	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000602	0.00264	CcSEcCtD
Guanfacine—Dyspnoea—Niacin—atherosclerosis	0.000599	0.00263	CcSEcCtD
Guanfacine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000598	0.00263	CcSEcCtD
Guanfacine—Insomnia—Pravastatin—atherosclerosis	0.000598	0.00263	CcSEcCtD
Guanfacine—Somnolence—Niacin—atherosclerosis	0.000597	0.00262	CcSEcCtD
Guanfacine—Paraesthesia—Pravastatin—atherosclerosis	0.000594	0.00261	CcSEcCtD
Guanfacine—Dyspepsia—Niacin—atherosclerosis	0.000591	0.00259	CcSEcCtD
Guanfacine—Dyspnoea—Pravastatin—atherosclerosis	0.000589	0.00259	CcSEcCtD
Guanfacine—Decreased appetite—Niacin—atherosclerosis	0.000584	0.00256	CcSEcCtD
Guanfacine—Dyspepsia—Pravastatin—atherosclerosis	0.000582	0.00256	CcSEcCtD
Guanfacine—Rash—Rosuvastatin—atherosclerosis	0.000582	0.00255	CcSEcCtD
Guanfacine—Dermatitis—Rosuvastatin—atherosclerosis	0.000581	0.00255	CcSEcCtD
Guanfacine—Abdominal pain—Simvastatin—atherosclerosis	0.000578	0.00254	CcSEcCtD
Guanfacine—Headache—Rosuvastatin—atherosclerosis	0.000578	0.00254	CcSEcCtD
Guanfacine—Hypersensitivity—Lovastatin—atherosclerosis	0.000576	0.00253	CcSEcCtD
Guanfacine—Decreased appetite—Pravastatin—atherosclerosis	0.000575	0.00252	CcSEcCtD
Guanfacine—Fatigue—Pravastatin—atherosclerosis	0.00057	0.0025	CcSEcCtD
Guanfacine—Constipation—Pravastatin—atherosclerosis	0.000565	0.00248	CcSEcCtD
Guanfacine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000565	0.00248	CcSEcCtD
Guanfacine—Asthenia—Lovastatin—atherosclerosis	0.000561	0.00246	CcSEcCtD
Guanfacine—Pruritus—Lovastatin—atherosclerosis	0.000553	0.00243	CcSEcCtD
Guanfacine—Asthenia—Ezetimibe—atherosclerosis	0.00055	0.00242	CcSEcCtD
Guanfacine—Gastrointestinal pain—Niacin—atherosclerosis	0.000549	0.00241	CcSEcCtD
Guanfacine—Nausea—Rosuvastatin—atherosclerosis	0.000548	0.00241	CcSEcCtD
Guanfacine—Feeling abnormal—Pravastatin—atherosclerosis	0.000545	0.00239	CcSEcCtD
Guanfacine—Pruritus—Ezetimibe—atherosclerosis	0.000543	0.00238	CcSEcCtD
Guanfacine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000541	0.00237	CcSEcCtD
Guanfacine—Hypersensitivity—Simvastatin—atherosclerosis	0.000539	0.00237	CcSEcCtD
Guanfacine—Diarrhoea—Lovastatin—atherosclerosis	0.000535	0.00235	CcSEcCtD
Guanfacine—Abdominal pain—Niacin—atherosclerosis	0.000531	0.00233	CcSEcCtD
Guanfacine—Asthenia—Simvastatin—atherosclerosis	0.000525	0.0023	CcSEcCtD
Guanfacine—Diarrhoea—Ezetimibe—atherosclerosis	0.000525	0.0023	CcSEcCtD
Guanfacine—Abdominal pain—Pravastatin—atherosclerosis	0.000523	0.00229	CcSEcCtD
Guanfacine—Pruritus—Simvastatin—atherosclerosis	0.000517	0.00227	CcSEcCtD
Guanfacine—Dizziness—Lovastatin—atherosclerosis	0.000517	0.00227	CcSEcCtD
Guanfacine—Dizziness—Ezetimibe—atherosclerosis	0.000507	0.00223	CcSEcCtD
Guanfacine—Diarrhoea—Simvastatin—atherosclerosis	0.0005	0.0022	CcSEcCtD
Guanfacine—Vomiting—Lovastatin—atherosclerosis	0.000497	0.00218	CcSEcCtD
Guanfacine—Hypersensitivity—Niacin—atherosclerosis	0.000495	0.00217	CcSEcCtD
Guanfacine—Rash—Lovastatin—atherosclerosis	0.000493	0.00216	CcSEcCtD
Guanfacine—Dermatitis—Lovastatin—atherosclerosis	0.000493	0.00216	CcSEcCtD
Guanfacine—Headache—Lovastatin—atherosclerosis	0.00049	0.00215	CcSEcCtD
Guanfacine—Vomiting—Ezetimibe—atherosclerosis	0.000488	0.00214	CcSEcCtD
Guanfacine—Hypersensitivity—Pravastatin—atherosclerosis	0.000487	0.00214	CcSEcCtD
Guanfacine—Dizziness—Simvastatin—atherosclerosis	0.000484	0.00212	CcSEcCtD
Guanfacine—Rash—Ezetimibe—atherosclerosis	0.000484	0.00212	CcSEcCtD
Guanfacine—Dermatitis—Ezetimibe—atherosclerosis	0.000483	0.00212	CcSEcCtD
Guanfacine—Asthenia—Niacin—atherosclerosis	0.000482	0.00212	CcSEcCtD
Guanfacine—Headache—Ezetimibe—atherosclerosis	0.00048	0.00211	CcSEcCtD
Guanfacine—Pruritus—Niacin—atherosclerosis	0.000475	0.00209	CcSEcCtD
Guanfacine—Asthenia—Pravastatin—atherosclerosis	0.000474	0.00208	CcSEcCtD
Guanfacine—Pruritus—Pravastatin—atherosclerosis	0.000468	0.00205	CcSEcCtD
Guanfacine—Vomiting—Simvastatin—atherosclerosis	0.000465	0.00204	CcSEcCtD
Guanfacine—Nausea—Lovastatin—atherosclerosis	0.000464	0.00204	CcSEcCtD
Guanfacine—Rash—Simvastatin—atherosclerosis	0.000461	0.00202	CcSEcCtD
Guanfacine—Dermatitis—Simvastatin—atherosclerosis	0.000461	0.00202	CcSEcCtD
Guanfacine—Diarrhoea—Niacin—atherosclerosis	0.000459	0.00202	CcSEcCtD
Guanfacine—Headache—Simvastatin—atherosclerosis	0.000458	0.00201	CcSEcCtD
Guanfacine—Nausea—Ezetimibe—atherosclerosis	0.000456	0.002	CcSEcCtD
Guanfacine—Diarrhoea—Pravastatin—atherosclerosis	0.000452	0.00199	CcSEcCtD
Guanfacine—Dizziness—Niacin—atherosclerosis	0.000444	0.00195	CcSEcCtD
Guanfacine—Dizziness—Pravastatin—atherosclerosis	0.000437	0.00192	CcSEcCtD
Guanfacine—Nausea—Simvastatin—atherosclerosis	0.000434	0.00191	CcSEcCtD
Guanfacine—Vomiting—Niacin—atherosclerosis	0.000427	0.00187	CcSEcCtD
Guanfacine—Rash—Niacin—atherosclerosis	0.000423	0.00186	CcSEcCtD
Guanfacine—Dermatitis—Niacin—atherosclerosis	0.000423	0.00186	CcSEcCtD
Guanfacine—Headache—Niacin—atherosclerosis	0.000421	0.00185	CcSEcCtD
Guanfacine—Vomiting—Pravastatin—atherosclerosis	0.00042	0.00185	CcSEcCtD
Guanfacine—Rash—Pravastatin—atherosclerosis	0.000417	0.00183	CcSEcCtD
Guanfacine—Dermatitis—Pravastatin—atherosclerosis	0.000416	0.00183	CcSEcCtD
Guanfacine—Headache—Pravastatin—atherosclerosis	0.000414	0.00182	CcSEcCtD
Guanfacine—Nausea—Niacin—atherosclerosis	0.000399	0.00175	CcSEcCtD
Guanfacine—Diclofenac—PTGS2—atherosclerosis	0.000398	0.0476	CrCbGaD
Guanfacine—Nausea—Pravastatin—atherosclerosis	0.000393	0.00172	CcSEcCtD
Guanfacine—Diclofenac—ALB—atherosclerosis	0.000355	0.0424	CrCbGaD
Guanfacine—ADRA2A—Signaling Pathways—VWF—atherosclerosis	2.57e-05	0.000252	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	2.55e-05	0.00025	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.55e-05	0.00025	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	2.53e-05	0.000249	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TGFB1—atherosclerosis	2.53e-05	0.000248	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	2.53e-05	0.000248	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KNG1—atherosclerosis	2.52e-05	0.000248	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AGTR1—atherosclerosis	2.51e-05	0.000246	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	2.5e-05	0.000245	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.5e-05	0.000245	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LPA—atherosclerosis	2.5e-05	0.000245	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	2.48e-05	0.000243	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.47e-05	0.000243	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.47e-05	0.000242	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCL2—atherosclerosis	2.46e-05	0.000242	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PLG—atherosclerosis	2.45e-05	0.00024	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALOX5—atherosclerosis	2.44e-05	0.00024	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—BGN—atherosclerosis	2.42e-05	0.000237	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.4e-05	0.000236	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOA5—atherosclerosis	2.39e-05	0.000235	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ABCA1—atherosclerosis	2.39e-05	0.000234	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	2.37e-05	0.000233	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.32e-05	0.000228	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SOCS3—atherosclerosis	2.32e-05	0.000227	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	2.31e-05	0.000227	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.3e-05	0.000226	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.28e-05	0.000224	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	2.27e-05	0.000223	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.26e-05	0.000222	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.25e-05	0.000221	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.25e-05	0.000221	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	2.24e-05	0.00022	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	2.24e-05	0.00022	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP3—atherosclerosis	2.24e-05	0.00022	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	2.23e-05	0.000219	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF2—atherosclerosis	2.23e-05	0.000219	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALOX5—atherosclerosis	2.22e-05	0.000218	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	2.21e-05	0.000217	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NAMPT—atherosclerosis	2.19e-05	0.000215	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	2.18e-05	0.000214	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	2.18e-05	0.000214	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	2.18e-05	0.000214	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.18e-05	0.000214	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LIPC—atherosclerosis	2.17e-05	0.000214	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCG1—atherosclerosis	2.17e-05	0.000213	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOB—atherosclerosis	2.16e-05	0.000212	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOC3—atherosclerosis	2.16e-05	0.000212	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LDLR—atherosclerosis	2.15e-05	0.000211	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—CXCL8—atherosclerosis	2.14e-05	0.00021	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EDN1—atherosclerosis	2.13e-05	0.000209	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL5—atherosclerosis	2.11e-05	0.000207	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CETP—atherosclerosis	2.1e-05	0.000206	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—F2—atherosclerosis	2.1e-05	0.000206	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—VEGFA—atherosclerosis	2.09e-05	0.000205	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LPL—atherosclerosis	2.06e-05	0.000203	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.06e-05	0.000202	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—HMOX1—atherosclerosis	2.05e-05	0.000201	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—FABP4—atherosclerosis	2.04e-05	0.000201	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LCAT—atherosclerosis	2.04e-05	0.000201	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SCARB1—atherosclerosis	2.01e-05	0.000197	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	2.01e-05	0.000197	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	2.01e-05	0.000197	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA4—atherosclerosis	2e-05	0.000197	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NAMPT—atherosclerosis	2e-05	0.000196	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.98e-05	0.000195	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LIPC—atherosclerosis	1.98e-05	0.000195	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—MAPK3—atherosclerosis	1.98e-05	0.000194	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOC3—atherosclerosis	1.97e-05	0.000193	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.97e-05	0.000193	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOB—atherosclerosis	1.96e-05	0.000193	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LDLR—atherosclerosis	1.96e-05	0.000192	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.96e-05	0.000192	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	1.95e-05	0.000192	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	1.95e-05	0.000191	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TGFB1—atherosclerosis	1.92e-05	0.000188	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	1.92e-05	0.000188	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CETP—atherosclerosis	1.91e-05	0.000188	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GSTM1—atherosclerosis	1.91e-05	0.000187	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	1.9e-05	0.000187	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.9e-05	0.000186	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—LPL—atherosclerosis	1.87e-05	0.000184	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	1.87e-05	0.000183	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PLG—atherosclerosis	1.86e-05	0.000182	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.83e-05	0.00018	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GPX1—atherosclerosis	1.83e-05	0.000179	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.82e-05	0.000179	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	1.81e-05	0.000178	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.78e-05	0.000175	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CD36—atherosclerosis	1.78e-05	0.000175	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AGT—atherosclerosis	1.77e-05	0.000173	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT1—atherosclerosis	1.76e-05	0.000173	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	1.76e-05	0.000173	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—LEP—atherosclerosis	1.73e-05	0.00017	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOE—atherosclerosis	1.73e-05	0.00017	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.73e-05	0.00017	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.73e-05	0.000169	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.73e-05	0.000169	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.73e-05	0.000169	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.73e-05	0.000169	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	1.71e-05	0.000168	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.71e-05	0.000168	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	1.71e-05	0.000168	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.7e-05	0.000167	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	1.7e-05	0.000167	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.69e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	1.69e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—MTHFR—atherosclerosis	1.69e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARA—atherosclerosis	1.65e-05	0.000162	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	1.65e-05	0.000162	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPA—atherosclerosis	1.65e-05	0.000162	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOB—atherosclerosis	1.64e-05	0.000161	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—F2—atherosclerosis	1.63e-05	0.00016	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	1.63e-05	0.00016	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	1.61e-05	0.000159	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AGT—atherosclerosis	1.6e-05	0.000157	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	1.6e-05	0.000157	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BGN—atherosclerosis	1.59e-05	0.000157	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.58e-05	0.000155	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOE—atherosclerosis	1.57e-05	0.000154	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LPL—atherosclerosis	1.57e-05	0.000154	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	1.56e-05	0.000153	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.56e-05	0.000153	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAV1—atherosclerosis	1.56e-05	0.000153	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOA1—atherosclerosis	1.55e-05	0.000152	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.54e-05	0.000151	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	1.52e-05	0.00015	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.52e-05	0.000149	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	1.5e-05	0.000147	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	1.48e-05	0.000146	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—INS—atherosclerosis	1.48e-05	0.000145	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	1.48e-05	0.000145	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.47e-05	0.000144	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	1.45e-05	0.000143	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.45e-05	0.000142	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	1.43e-05	0.00014	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	1.42e-05	0.000139	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOB—atherosclerosis	1.39e-05	0.000136	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	1.37e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—atherosclerosis	1.37e-05	0.000134	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	1.36e-05	0.000133	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.35e-05	0.000133	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—INS—atherosclerosis	1.34e-05	0.000132	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	1.34e-05	0.000132	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—atherosclerosis	1.33e-05	0.000131	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—LPL—atherosclerosis	1.33e-05	0.00013	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.32e-05	0.00013	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.32e-05	0.000129	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	1.31e-05	0.000129	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	1.31e-05	0.000129	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LIPC—atherosclerosis	1.31e-05	0.000128	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	1.3e-05	0.000128	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOC3—atherosclerosis	1.3e-05	0.000128	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	1.3e-05	0.000127	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	1.3e-05	0.000127	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPX1—atherosclerosis	1.29e-05	0.000127	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LDLR—atherosclerosis	1.29e-05	0.000127	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOB—atherosclerosis	1.27e-05	0.000124	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CETP—atherosclerosis	1.26e-05	0.000124	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CD36—atherosclerosis	1.26e-05	0.000124	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	1.25e-05	0.000123	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—F2—atherosclerosis	1.24e-05	0.000122	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.23e-05	0.000121	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—atherosclerosis	1.23e-05	0.000121	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—LPL—atherosclerosis	1.21e-05	0.000119	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.21e-05	0.000119	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.19e-05	0.000117	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	1.18e-05	0.000116	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPX1—atherosclerosis	1.18e-05	0.000116	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—NOS3—atherosclerosis	1.18e-05	0.000116	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARA—atherosclerosis	1.17e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	1.15e-05	0.000113	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CD36—atherosclerosis	1.15e-05	0.000113	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.14e-05	0.000112	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AGT—atherosclerosis	1.14e-05	0.000111	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	1.13e-05	0.000111	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—INS—atherosclerosis	1.12e-05	0.00011	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOE—atherosclerosis	1.11e-05	0.000109	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	1.11e-05	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	1.1e-05	0.000108	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAV1—atherosclerosis	1.1e-05	0.000108	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOA1—atherosclerosis	1.1e-05	0.000108	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	1.09e-05	0.000107	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.09e-05	0.000107	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	1.08e-05	0.000107	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—atherosclerosis	1.08e-05	0.000106	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARA—atherosclerosis	1.07e-05	0.000105	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	1.04e-05	0.000102	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AGT—atherosclerosis	1.04e-05	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	1.03e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	1.03e-05	0.000101	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.02e-05	9.99e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOE—atherosclerosis	1.01e-05	9.96e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	1.01e-05	9.93e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	1.01e-05	9.91e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAV1—atherosclerosis	1e-05	9.87e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1e-05	9.86e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOA1—atherosclerosis	1e-05	9.85e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	9.83e-06	9.66e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—atherosclerosis	9.69e-06	9.51e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—INS—atherosclerosis	9.5e-06	9.33e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	9.34e-06	9.17e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	9.25e-06	9.08e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	9.15e-06	8.99e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	8.83e-06	8.68e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—atherosclerosis	8.83e-06	8.67e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—atherosclerosis	8.72e-06	8.57e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	8.72e-06	8.57e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—atherosclerosis	8.71e-06	8.55e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—INS—atherosclerosis	8.66e-06	8.51e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	8.57e-06	8.42e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	8.43e-06	8.28e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOB—atherosclerosis	8.36e-06	8.21e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—NOS3—atherosclerosis	8.33e-06	8.18e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	8.29e-06	8.15e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GSTM1—atherosclerosis	8.13e-06	7.98e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—LPL—atherosclerosis	7.98e-06	7.84e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—atherosclerosis	7.94e-06	7.8e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	7.89e-06	7.75e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	7.81e-06	7.67e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX1—atherosclerosis	7.78e-06	7.64e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	7.67e-06	7.54e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	7.65e-06	7.52e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—atherosclerosis	7.62e-06	7.48e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—NOS3—atherosclerosis	7.6e-06	7.46e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CD36—atherosclerosis	7.58e-06	7.45e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.18e-06	7.06e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	7.08e-06	6.96e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARA—atherosclerosis	7.05e-06	6.92e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	7.02e-06	6.89e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—atherosclerosis	6.95e-06	6.82e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AGT—atherosclerosis	6.83e-06	6.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	6.7e-06	6.58e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOE—atherosclerosis	6.69e-06	6.57e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAV1—atherosclerosis	6.63e-06	6.51e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOA1—atherosclerosis	6.61e-06	6.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	6.5e-06	6.39e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	6.46e-06	6.34e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.04e-06	5.93e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	5.96e-06	5.85e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—atherosclerosis	5.83e-06	5.72e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—INS—atherosclerosis	5.71e-06	5.61e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—atherosclerosis	5.41e-06	5.31e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—atherosclerosis	5.24e-06	5.14e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NOS3—atherosclerosis	5.01e-06	4.92e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	4.9e-06	4.81e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.58e-06	4.5e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	4.52e-06	4.44e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—atherosclerosis	3.83e-06	3.76e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—atherosclerosis	3.49e-06	3.43e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—atherosclerosis	2.3e-06	2.26e-05	CbGpPWpGaD
